Clinical observations of sertindole-treated schizophrenic patients;Klinische Beobachtungen an schizophrenen Patienten unter behandlung mit Sertindol

Psychopharmakotherapie

Volumn 8, Issue 1, 2001, Pages 28-34

  Bickmann, E ^a   Grosse K ^a   Laux, G ^a   Frau, C A ^a   Frau, S K ^a   Frau, P H ^a   Frau, B K ^a   Herr, A E ^a   Frau, M M ^a   Frau, R T ^a  

^a Bezirkskrankenhaus Gabersee ^*  (Germany)

Author keywords

Cardiovascular side effects; Extrapyramidal side effects; Non compliance; Non response; Schizophrenia; Sertindole

Indexed keywords

NEUROLEPTIC AGENT; SERTINDOLE;

ADULT; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEART ARRHYTHMIA; HUMAN; MALE; NEGATIVE SYNDROME; PATIENT COMPLIANCE; PSYCHOPHARMACOTHERAPY; QT INTERVAL; REVIEW; RISK FACTOR; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0035113179     PISSN: 09446877     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Negative symptoms in schizophrenia
2. Sertindole, a new atypical antipsychotic for the treatment of schizophrenia
3. Behavioural effects of sertindole, risperidone, clozapine and haloperidol in Cebus monkeys
4. Long term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia
5. Effect of sertindole on raised mesolimbic dopaminergic activity in the rat
6. QT-Verlängerung und das neue, atypische Neuroleptikum Sertindol
7. Pharmacological profile of the atypical neuroleptic sertindole
8. 1 receptors (ex vivo radio receptor binding studies)
9. Atypische neuroleptika. Pharmakologie und ihre bedeutung
10. Therapie schizophrener Patienten mit Minus-symptomatik
11. Neuroleptic induced deficit syndrome
12. The atypical antipsychotic sertindole: A case series
13. Positive und Negative Symptomatik der Schizophrenie
14. Neuroleptic treatment of negative symptoms in schizophrenic patients. Efficacy problems methodological difficulties
15. Review: Treatment of schizophrenia. State of the art
16. Sertindole: A limbic-selective neuroleptic with potent anxiolytic effects
17. Neurochemical and in vivo pharmacological profile of sertindole, a limbic-selective neuroleptic compound
18. Differential effects of repeated administration of novel antipsychotic drugs on the activity of midbrain dopamine neurons in the rat
19. Electrophysiological profile of a new atypical neuroleptic, sertindole, on midbrain dopamine neurons in rats: Acute and repeated treatment
20. Sertindole, a new neuroleptic with extreme selectivity on A 10 versus A 9 dopamine neurones in the rat
21. Sertindole in the treatment of psychosis in schizophrenia: Efficacy and safety
22. A randomised, controlled, dose-ranging trial of sertindole in patients with schizophrenia
23. A controlled, dose-response study of sertindole and haloperidol in schizophrenia